Doczone Plus 1gm/125mg Injection
By Doczone Plus
Rx
1 Injection in a Vial

Composition
Ceftriaxone(1gm) + Tazobactum(125mg)

Manufacturer - Docventures pharmaceutical Pvt Ltd
No.7, 2nd Floor, Opp to Govt School Puttenhalli Circle, Kothnur Main Road J.P.Nagar 7th Phase Bangalore-560078.

Expires on or after
October, 2025

liver
Doczone Plus 1gm/125mg Injection should be used carefully in individuals with severe liver disease. It may be necessary to adjust the dosage of this injection in such cases. It is important to consult your doctor before using this product for guidance. However, dose adjustment of Doczone Plus 1gm/125mg Injection is generally not advised for patients with mild to moderate liver disease. If you have any concerns about using this injection with liver issues, make sure to seek advice from your healthcare provider.

kidney
There is limited information on using Doczone Plus 1gm/125mg Injection in patients with kidney disease. Please consult your doctor for proper guidance before use.

alcohol
When taking Doczone Plus 1gm/125mg Injection, it is safe to consume alcohol without causing harmful side effects.

driving
Doczone Plus 1gm/125mg Injection can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these side effects.

pregnancy
Doczone Plus 1gm/125mg Injection is generally safe during pregnancy. Animal studies show minimal effects on the baby, but human studies are limited.

breastfeeding
During breastfeeding, caution is advised when using Doczone Plus 1gm/125mg Injection. It is recommended to postpone breastfeeding until the mother's treatment is finished and the drug has cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹128
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024